Relationship between coffee consumption, sleep duration and smoking status with elastographic parameters of liver steatosis and fibrosis; controlled attenuation …

I Mikolasevic, V Domislovic… - … journal of clinical …, 2021 - Wiley Online Library
Aim our aim was to explore the association between life habits and the controlled
attenuation parameter (CAP) and liver stiffness measurements (LSM) as the surrogate …

[HTML][HTML] Coffee intake is associated with a lower liver stiffness in patients with non-alcoholic fatty liver disease, hepatitis C, and hepatitis B

A Hodge, S Lim, E Goh, O Wong, P Marsh, V Knight… - Nutrients, 2017 - mdpi.com
There is emerging evidence for the positive effects or benefits of coffee in patients with liver
disease. We conducted a retrospective cross-sectional study on patients with non-alcoholic …

Prospective evaluation of non-alcoholic fatty liver disease by elastographic methods of liver steatosis and fibrosis; controlled attenuation parameter and liver stiffness …

I Mikolasevic, VL Zanko, I Jakopcic… - Journal of Diabetes and …, 2020 - Elsevier
Aims To examine the temporal changes of both controlled attenuation parameter (CAP) and
liver stiffness measurements (LSM), assessed by Fibroscan, in a large sample of patients …

Coffee and herbal tea consumption is associated with lower liver stiffness in the general population: The Rotterdam study

LJM Alferink, J Fittipaldi, JC Kiefte-de Jong, P Taimr… - Journal of …, 2017 - Elsevier
Background & Aims Coffee and tea have been proposed to limit the progression of liver
fibrosis in established liver disease, but it is unknown if this is also true for subclinical …

Coffee consumption is associated with lower liver stiffness: a nationally representative study

S Niezen, M Mehta, ZG Jiang, EB Tapper - Clinical Gastroenterology and …, 2022 - Elsevier
Background & Aims Coffee is associated with a reduced risk of liver disease. This
association is limited by important sources of confounding such as recall bias, healthy user …

Increased liver stiffness in patients with severe sleep apnoea and metabolic comorbidities

W Trzepizur, J Boursier, M Le Vaillant… - European …, 2018 - Eur Respiratory Soc
The goal of this study was to assess the relationship between the severity of obstructive
sleep apnoea (OSA) and liver stiffness measurement (LSM), one of the most accurate …

[HTML][HTML] Discrimination of individuals in a general population at high-risk for alcoholic and non-alcoholic fatty liver disease based on liver stiffness: a cross section …

M Baba, K Furuya, H Bandou, K Kasai… - BMC gastroenterology, 2011 - Springer
Background Factors associated with liver stiffness (LS) are unknown and normal reference
values for LS have not been established. Individuals at high risk for alcoholic (ALD) and non …

[HTML][HTML] Prevalence of hepatic steatosis as assessed by controlled attenuation parameter (CAP) in subjects with metabolic risk factors in primary care. A population …

N Fabrellas, R Hernandez, I Graupera, E Sola… - PloS one, 2018 - journals.plos.org
Background Primary care is the ideal setting for early identification of patients with non-
alcoholic fatty liver disease (NAFLD). NAFLD is a potentially progressive disease that may …

Screening diabetic patients for non-alcoholic fatty liver disease with controlled attenuation parameter and liver stiffness measurements: a prospective cohort study

R Kwok, KC Choi, GLH Wong, Y Zhang, HLY Chan… - Gut, 2016 - gut.bmj.com
Objective Type 2 diabetes is an important risk factor for non-alcoholic fatty liver disease
(NAFLD), but current guidelines provide conflicting recommendations on whether diabetic …

Association between smoking and liver fibrosis among patients with nonalcoholic fatty liver disease

H Ou, Y Fu, W Liao, C Zheng… - Canadian Journal of …, 2019 - Wiley Online Library
Objective. We aimed at analyzing the role of smoking in hepatic fibrosis in patients with
nonalcoholic fatty liver disease (NAFLD) and at exploring the related risk factors. Methods …